Besides, the expression of EZH2 also involved in acquiring M2 phenotype of tumor-associated macrophages (TAMs), activation of dendritic cells (DCs) to mediate epigenetic modification in immunotherapy [55,56]. This evidence concerns the gene EZH2 and neoplasm.